Introduction: Accumulated evidence suggests that pulmonary fibrosis is a common
complication of COVID-19. Fibrotic post-coronavirus lung changes are similar to the …

Aim: The aim of this study was to measure the antinucleocapsid level of SARS-CoV-2 IgG to
identify the number of asymptomatic cases of COVID-19 after infection in a population of …

Aim. Long-COVID syndrome is still under broad investigation. It is known, however, that the
consequences of COVID-19 disease can permanently affect the health and quality of life of …

Aim: Our goal was to investigate if the treatment with omalizumab due to severe asthma is a
risk factor of severe COVID-19 pneumonia and if severe acute respiratory syndrome …

Aim: We would like to highlight the rarity of pneumomediastinum and subcutaneous
emphysema in nonventilated COVID-19 patient. Case study: A 50-year-old man was …

Abstract Introduction: The World Health Organization (WHO) recommended dexamethasone
as the only effective drug for treatment severe cases of COVID-19. Aim: To study the …

I ntroduction: Severe acute respiratory syndrome, coronavirus type 2 (SARS--CoV-2) has
become a global threat for every healthcare system, and the coronavirus disease 2019 …

Polish Annals of Medicine Page 1 1 Pol Ann Med. [in Press] Research paper Samuel Stróż1, Piotr
Kosiorek1, Edyta Zbroch2, Bożena Mikołuć3, Anna Stasiak-Barmuta1 1 Department of Clinical …

Polish Annals of Medicine Page 1 77 Pol Ann Med. 2023;30(1):77–81 Case report Anna
Zaleska, Anna Radlińska Department of Internal Medicine, Pneumonology and Allergology …

I ntroduction: The most common complications of COVID-19 infection are: pneumonia, acute
respiratory distress syndrome, pulmonary fibrosis, pulmonary embolism, pneumothorax and …